Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2019

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Schedule of Finite-Lived Intangible Assets

The following table summarizes our intangible assets, net (in millions):

	September 30, 2019										December 31, 2018
	Gross  Carrying Amount		Accumulated Amortization			Foreign Currency Translation Adjustment			Net Carrying Amount		Gross  Carrying Amount		Accumulated Amortization			Foreign Currency Translation Adjustment			Net Carrying Amount
Finite-lived assets:
Intangible asset - sofosbuvir	$	10,720	$	(4,078	)	$	—		$	6,642	$	10,720	$	(3,554	)	$	—		$	7,166
Intangible asset - axicabtagene ciloleucel (DLBCL)	6,200		(675		)	—			5,525		6,200		(416		)	—			5,784
Intangible asset - Ranexa	688		(688		)	—			—		688		(678		)	—			10
Other	1,098		(434		)	(7		)	657		1,096		(359		)	(3		)	734
Total finite-lived assets	18,706		(5,875		)	(7		)	12,824		18,704		(5,007		)	(3		)	13,694
Indefinite-lived assets - in process research & development	2,047		—			(7		)	2,040		2,047		—			(3		)	2,044
Total intangible assets	$	20,753	$	(5,875	)	$	(14	)	$	14,864	$	20,751	$	(5,007	)	$	(6	)	$	15,738

Schedule of Indefinite-Lived Intangible Assets

The following table summarizes our intangible assets, net (in millions):

	September 30, 2019										December 31, 2018
	Gross  Carrying Amount		Accumulated Amortization			Foreign Currency Translation Adjustment			Net Carrying Amount		Gross  Carrying Amount		Accumulated Amortization			Foreign Currency Translation Adjustment			Net Carrying Amount
Finite-lived assets:
Intangible asset - sofosbuvir	$	10,720	$	(4,078	)	$	—		$	6,642	$	10,720	$	(3,554	)	$	—		$	7,166
Intangible asset - axicabtagene ciloleucel (DLBCL)	6,200		(675		)	—			5,525		6,200		(416		)	—			5,784
Intangible asset - Ranexa	688		(688		)	—			—		688		(678		)	—			10
Other	1,098		(434		)	(7		)	657		1,096		(359		)	(3		)	734
Total finite-lived assets	18,706		(5,875		)	(7		)	12,824		18,704		(5,007		)	(3		)	13,694
Indefinite-lived assets - in process research & development	2,047		—			(7		)	2,040		2,047		—			(3		)	2,044
Total intangible assets	$	20,753	$	(5,875	)	$	(14	)	$	14,864	$	20,751	$	(5,007	)	$	(6	)	$	15,738

Schedule of Estimated Future Amortization Expense

The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of September 30, 2019 (in millions):

Fiscal Year	Amount
2019 (remaining three months)	$	281
2020	1,125
2021	1,124
2022	1,124
2023	1,124
Thereafter	8,046
Total	$	12,824